dimethylphenylpiperazinium iodide has been researched along with Hyperglycemia in 1 studies
Dimethylphenylpiperazinium Iodide: A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jall, S | 1 |
| De Angelis, M | 1 |
| Lundsgaard, AM | 1 |
| Fritzen, AM | 1 |
| Nicolaisen, TS | 1 |
| Klein, AB | 1 |
| Novikoff, A | 1 |
| Sachs, S | 1 |
| Richter, EA | 1 |
| Kiens, B | 1 |
| Schramm, KW | 1 |
| Tschöp, MH | 1 |
| Stemmer, K | 1 |
| Clemmensen, C | 1 |
| Müller, TD | 1 |
| Kleinert, M | 1 |
1 other study available for dimethylphenylpiperazinium iodide and Hyperglycemia
| Article | Year |
|---|---|
Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity.
Topics: Animals; Blood Glucose; Catecholamines; Dimethylphenylpiperazinium Iodide; Hyperglycemia; Insulin Re | 2020 |